These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 19838939)

  • 61. Cellular and molecular consequences of peroxisome proliferator-activated receptor-gamma activation in ovarian cancer cells.
    Vignati S; Albertini V; Rinaldi A; Kwee I; Riva C; Oldrini R; Capella C; Bertoni F; Carbone GM; Catapano CV
    Neoplasia; 2006 Oct; 8(10):851-61. PubMed ID: 17032502
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Identification of novel markers of alternative activation and potential endogenous PPARγ ligand production mechanisms in human IL-4 stimulated differentiating macrophages.
    Czimmerer Z; Varga T; Poliska S; Nemet I; Szanto A; Nagy L
    Immunobiology; 2012 Dec; 217(12):1301-14. PubMed ID: 22954708
    [TBL] [Abstract][Full Text] [Related]  

  • 63. 5-Oxo-ETE analogs and the proliferation of cancer cells.
    O'Flaherty JT; Rogers LC; Paumi CM; Hantgan RR; Thomas LR; Clay CE; High K; Chen YQ; Willingham MC; Smitherman PK; Kute TE; Rao A; Cramer SD; Morrow CS
    Biochim Biophys Acta; 2005 Oct; 1736(3):228-36. PubMed ID: 16154383
    [TBL] [Abstract][Full Text] [Related]  

  • 64. 15-lipoxygenase metabolites of docosahexaenoic acid inhibit prostate cancer cell proliferation and survival.
    O'Flaherty JT; Hu Y; Wooten RE; Horita DA; Samuel MP; Thomas MJ; Sun H; Edwards IJ
    PLoS One; 2012; 7(9):e45480. PubMed ID: 23029040
    [TBL] [Abstract][Full Text] [Related]  

  • 65. WLIP derived from Lasiosphaera fenzlii Reich exhibits anti-tumor activity and induces cell cycle arrest through PPAR-γ associated pathways.
    Meng J; Fan Y; Su M; Chen C; Ren T; Wang J; Zhao Q
    Int Immunopharmacol; 2014 Mar; 19(1):37-44. PubMed ID: 24401848
    [TBL] [Abstract][Full Text] [Related]  

  • 66. CYP4F2 repression and a modified alpha-tocopherol (vitamin E) metabolism are two independent consequences of ethanol toxicity in human hepatocytes.
    Russo A; Bartolini D; Torquato P; Giusepponi D; Barola C; Galarini R; Birringer M; Lorkowski S; Galli F
    Toxicol In Vitro; 2017 Apr; 40():124-133. PubMed ID: 28062356
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Oxidative metabolism of linoleic acid modulates PPAR-beta/delta suppression of PPAR-gamma activity.
    Zuo X; Wu Y; Morris JS; Stimmel JB; Leesnitzer LM; Fischer SM; Lippman SM; Shureiqi I
    Oncogene; 2006 Feb; 25(8):1225-41. PubMed ID: 16288226
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Dietary lutein modulates growth and survival genes in prostate cancer cells.
    Rafi MM; Kanakasabai S; Gokarn SV; Krueger EG; Bright JJ
    J Med Food; 2015 Feb; 18(2):173-81. PubMed ID: 25162762
    [TBL] [Abstract][Full Text] [Related]  

  • 69. 20-carboxy-arachidonic acid is a dual activator of peroxisome proliferator-activated receptors alpha and gamma.
    Fang X; Dillon JS; Hu S; Harmon SD; Yao J; Anjaiah S; Falck JR; Spector AA
    Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):175-84. PubMed ID: 17164145
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Does the PGC-1/PPARgamma pathway play a role in Com-1/p8 mediated cell growth inhibition in prostate cancer?
    Jiang WG; Davies G; Kynaston H; Mason MD; Fodstad O
    Int J Mol Med; 2006 Dec; 18(6):1169-75. PubMed ID: 17089023
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Saccharomyces boulardii activates expression of peroxisome proliferator-activated receptor-gamma in HT-29 cells].
    Lee SK; Kim HJ; Chi SG; Jang JY; Nam KD; Kim NH; Joo KR; Dong SH; Kim BH; Chang YW; Lee JI; Chang R
    Korean J Gastroenterol; 2005 May; 45(5):328-34. PubMed ID: 15908765
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Evidence that arachidonate 15-lipoxygenase 2 is a negative cell cycle regulator in normal prostate epithelial cells.
    Tang S; Bhatia B; Maldonado CJ; Yang P; Newman RA; Liu J; Chandra D; Traag J; Klein RD; Fischer SM; Chopra D; Shen J; Zhau HE; Chung LW; Tang DG
    J Biol Chem; 2002 May; 277(18):16189-201. PubMed ID: 11839751
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Anti-proliferative effect of a putative endocannabinoid, 2-arachidonylglyceryl ether in prostate carcinoma cells.
    Nithipatikom K; Isbell MA; Endsley MP; Woodliff JE; Campbell WB
    Prostaglandins Other Lipid Mediat; 2011 Feb; 94(1-2):34-43. PubMed ID: 21167293
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Addendum: Gamma-tocopherol, cox-2, and cancer risk.
    McCarty MF
    Med Hypotheses; 2012 Apr; 78(4):554. PubMed ID: 22285625
    [No Abstract]   [Full Text] [Related]  

  • 75. Downregulation of vascular endothelial growth factor and induction of tumor dormancy by 15-lipoxygenase-2 in prostate cancer.
    Tang Y; Wang MT; Chen Y; Yang D; Che M; Honn KV; Akers GD; Johnson SR; Nie D
    Int J Cancer; 2009 Apr; 124(7):1545-51. PubMed ID: 19089921
    [TBL] [Abstract][Full Text] [Related]  

  • 76. 15-lipoxygenase-1 in colorectal cancer: a review.
    Bhattacharya S; Mathew G; Jayne DG; Pelengaris S; Khan M
    Tumour Biol; 2009; 30(4):185-99. PubMed ID: 19752603
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Peroxisome proliferator activated receptor γ protein expression is asymmetrically distributed in primary lung tumor and metastatic to lung osteosarcoma samples and does not correlate with gene methylation.
    Herrera CL; Kim DY; Kumar SR; Bryan JN
    BMC Vet Res; 2015 Sep; 11():230. PubMed ID: 26334880
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A paracrine effect of 15 (S)-hydroxyeicosatetraenoic acid revealed in prostaglandin production by human follicular dendritic cell-like cells.
    Kim J; Choe J
    Prostaglandins Other Lipid Mediat; 2020 Dec; 151():106487. PubMed ID: 33007445
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Phenylbutyrate induces apoptosis and lipid accumulations via a peroxisome proliferator-activated receptor gamma-dependent pathway.
    Milkevitch M; Beardsley NJ; Delikatny EJ
    NMR Biomed; 2010 Jun; 23(5):473-9. PubMed ID: 20225233
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A novel approach to anticancer therapies: peroxisome proliferator activator-receptor-gamma as a new target therapy in the treatment of human urological cancer.
    Matsuyama M; Yoshimura R
    Endocr Metab Immune Disord Drug Targets; 2009 Mar; 9(1):76-83. PubMed ID: 19275683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.